Heidrich H, Gerke E, Nekarda H
Arzneimittelforschung. 1983;33(4):580-2.
In 52 patients with pathologically increased platelet aggregation the effect of a 4-day oral treatment of 500 mg, 1000 mg and 1500 mg calcium dobesilate (Dexium 500) on spontaneous platelet aggregation was assessed using PAT III of Breddin. In comparison to placebo 1500 mg calcium dobesilate reduced platelet aggregation significantly, 1000 mg and 500 mg calcium dobesilate, however, didn't influence platelet aggregation.
在52例血小板聚集病理性增加的患者中,采用布雷丁PAT III评估了500毫克、1000毫克和1500毫克羟苯磺酸钙(多贝斯500)进行为期4天的口服治疗对自发性血小板聚集的影响。与安慰剂相比,1500毫克羟苯磺酸钙显著降低了血小板聚集,然而,1000毫克和500毫克羟苯磺酸钙对血小板聚集没有影响。